These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39503880)

  • 1. Integration of single-cell and spatial transcriptome sequencing identifies CDKN2A as a senescent biomarker in endothelial cells implicating hepatocellular carcinoma malignancy.
    Ma Y; Yi C; Cai N; Chen J
    J Cancer Res Clin Oncol; 2024 Nov; 150(11):487. PubMed ID: 39503880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns.
    Wang C; Yang G; Feng G; Deng C; Zhang Q; Chen S
    Front Immunol; 2024; 15():1410603. PubMed ID: 39044829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Tong W; Zhong J; Yang Q; Lin H; Chen B; Lu T; Chen J; Luo N
    Front Immunol; 2024; 15():1414121. PubMed ID: 39530087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a senescence-related transcriptional signature to uncover molecular subtypes and key genes in hepatocellular carcinoma.
    He X; Liu F; Gong Q
    PLoS One; 2024; 19(10):e0311696. PubMed ID: 39383169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion.
    Su Z; Zhong Y; He Y; You L; Xin F; Wang L; Liu Z
    Front Immunol; 2024; 15():1469827. PubMed ID: 39555078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights.
    Li Y; Chen Y; Wang D; Wu L; Li T; An N; Yang H
    Front Immunol; 2024; 15():1442722. PubMed ID: 39081317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.
    Guo DZ; Zhang X; Zhang SQ; Zhang SY; Zhang XY; Yan JY; Dong SY; Zhu K; Yang XR; Fan J; Zhou J; Huang A
    Mol Cancer; 2024 Aug; 23(1):157. PubMed ID: 39095854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single-cell sequencing analysis.
    Qu C; Wu Q; Lu J; Li F
    Environ Toxicol; 2024 May; 39(5):2512-2527. PubMed ID: 38189188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Luo JP; Wang J; Huang JH
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34405225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell and spatial transcriptomics reveal apelin/APJ pathway's role in microvessel formation and tumour progression in hepatocellular carcinoma.
    Zhu Y; Zhang P; Huo X; Ling Y; Lv X; Lin S; Song H
    J Cell Mol Med; 2024 Oct; 28(20):e70152. PubMed ID: 39434201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A.
    Chen D; Wang J; Li Y; Xu C; Fanzheng M; Zhang P; Liu L
    Clin Transl Med; 2023 Sep; 13(9):e1418. PubMed ID: 37752791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent endothelial cells promote liver metastasis of uveal melanoma in single-cell resolution.
    Ma L; He X; Fu Y; Ge S; Yang Z
    J Transl Med; 2024 Jul; 22(1):605. PubMed ID: 38951874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma.
    Shi J; Wen K; Mui S; Li H; Liao H; He C; Yan Y; Zhou Z; Xiao Z
    Clin Transl Oncol; 2024 Sep; 26(9):2181-2197. PubMed ID: 38472558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis.
    Yildiz G; Arslan-Ergul A; Bagislar S; Konu O; Yuzugullu H; Gursoy-Yuzugullu O; Ozturk N; Ozen C; Ozdag H; Erdal E; Karademir S; Sagol O; Mizrak D; Bozkaya H; Ilk HG; Ilk O; Bilen B; Cetin-Atalay R; Akar N; Ozturk M
    PLoS One; 2013; 8(5):e64016. PubMed ID: 23691139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.